Nearly Two Months After New Hands-Free Law, Distracted Driving Remains Lower in Ohio
New data from Cambridge Mobile Telematics shows initial gains from law have continued CAMBRIDGE, Mass.–(BUSINESS…
News
Wedding Venue In Houston, The Bell Tower on 34th, Launches Inclusive Packages
The Bell Tower on 34th, a luxury wedding venue in Houston, near The Woodlands, has…
AI Visual Content Creation & Engagement Report Launched By ScottHall.Co
ScottHall.co, a digital marketing and software specialist team, has launched a new report that explores…
Streakk Has Launched a 3rd Generation Blockchain Infrastructure
Dubai, United Arab Emirates–(Newsfile Corp. – May 26, 2023) – Streakk has launched a 3rd…
Tenet Reports First Quarter 2023 Financial Results
Toronto, Ontario–(Newsfile Corp. – May 26, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Bluesky Digital Assets Corp., Announces Debt Settlement
Toronto, Ontario–(Newsfile Corp. – May 26, 2023) – Bluesky Digital Assets Corp., (CSE: BTC) (OTCQB:…
MyndTec Inc. Announces Grant of Stock Options in Connection with a Consulting Agreement
Mississauga, Ontario–(Newsfile Corp. – May 26, 2023) – MyndTec Inc. (CSE: MYTC) (“MyndTec” or the…
Healing System for Vaginal Tears Takes Top Prize at UCI Stella Zhang New Venture Competition
IRVINE, Calif.–(BUSINESS WIRE)–A promising treatment for vaginal tears impressed judges at the UCI Stella Zhang…
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023…
Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023…
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering …
Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering
26 May 2023 Biodexa Pharmaceuticals PLC Announces Closing of $3.32 Million Registered Direct Offering …
Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and…
Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and…
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
COMPASS Pathways to participate in upcoming Jefferies Healthcare Conference
LONDON, May 26, 2023 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
Results of the votes of the Combined Shareholders’ General Meeting of May 25, 2023
Daix (France), Long Island City (New York, United States), May 26, 2023 – Inventiva…
Legend Power Announces Recording Now Available for Fiscal Q2 2023 Financial Results Conference Call
Vancouver, British Columbia–(Newsfile Corp. – May 26, 2023) – Legend Power® Systems Inc. (TSXV: LPS)…